Eukaryotic initiation factor-2, gamma subunit, suppresses proliferation and regulates the cell cycle via the MAPK/ERK

Jielun Lu1,2, Shuyi Chen3,2, Huo Tan3

  • 1Department of Pediatrics, The First Affiliated Hospital of Guangzhou Medical University, 151 Yanjiang West Road, Yuexiu, Guangzhou, 510000, Guangdong, People's Republic of China.

Abstract

Insights

Eukaryotic translation initiation factor-2 subunit 3 (EIF2S3) is downregulated in acute myeloid leukemia (AML). Overexpression of EIF2S3 inhibits AML cell proliferation and tumorigenicity by affecting the MAPK/ERK signaling pathway.

Area of Science:

  • Molecular Biology
  • Oncology

Background:

  • Eukaryotic translation initiation factor-2 subunit 3 (EIF2S3) expression is reduced in non-small cell lung and colorectal cancers.
  • The role of EIF2S3 in leukemia remains largely unexplored.

Purpose of the Study:

  • To investigate the function of EIF2S3 in acute myeloid leukemia (AML).
  • To elucidate the underlying molecular mechanisms of EIF2S3 in AML.

Main Methods:

  • Quantitative PCR to assess EIF2S3 expression and correlate with AML patient prognosis.
  • Establishment of inducible HEL-EIF2S3 and HL-60-EIF2S3 cell lines.
  • Cell proliferation, cell cycle, and tumorigenicity assays (in vitro and in vivo).
  • Next-generation sequencing and Western blot analysis to identify molecular pathways involved.

Main Results:

  • EIF2S3 expression was significantly lower in AML patients compared to those in complete remission (CR).
  • Overexpression of EIF2S3 suppressed AML cell proliferation, induced cell cycle arrest at the G0/1 to S phase transition, and inhibited tumor formation.
  • Next-generation sequencing identified 479 differentially expressed genes, with several linked to the MAPK/ERK signaling pathway.
  • MAPK/ERK signaling pathway activity, indicated by ERK phosphorylation, was decreased upon EIF2S3 overexpression.

Conclusions:

  • EIF2S3 overexpression exerts tumor-suppressive effects in AML.
  • The observed inhibition of proliferation and tumorigenicity is mediated through the MAPK/ERK signaling pathway.
  • EIF2S3 represents a potential therapeutic target in AML.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.5K